While clinical studies on the effects of CFTR modulators on pulmonary function are abundant, investigations into their impact on the extrapulmonary effects, particularly liver damage in CF, are still limited, leaving uncertainties regarding their influence on the advancement of liver disease—Table 3. This evidence concerns the gene CFTR and cystic fibrosis.